The global bipolar forceps market size is expected to reach USD 1.1 billion by 2027, expanding at a CAGR of 4.7%, according to a new report by Grand View Research, Inc. Rising prevalence of chronic conditions, an increasing number of minimally invasive procedures, and the high volume of product launches are the factors augmenting the market. For instance, in November 2016, HOYA Group PENTAX Medical launched the bipolar hot hemostasis forceps - HemoStat WideCup at the JDDW 2016 Congress, Japan. The new device allows for easy bleeding control during endoscopic procedures. Such procedures have gained global interest, as they offer substantial clinical and financial benefits, resulting in reduced procedural complexities, early recovery, and costs.
The usage of bipolar forceps is expected to soar over the forecast period due to the increasing number of neurology and plastic surgeries. According to the American Association of Neurological Surgeons, 2017, an estimated 22.6 million patients suffer from neurological conditions, of which 13.8 million require surgery per year, globally. According to the Global Nursing and Healthcare Conference, 2016, approximately 234.0 million surgical procedures are performed globally. As per the American Society of Plastic Surgeons, around 17.5 million minimally invasive surgical procedures were performed in 2017, indicating a 2% rise from the previous year.
Request a free sample copy or view report summary: Bipolar Forceps Market Report
North America accounted for the largest share in 2019 owing to the rising prevalence of chronic diseases in the geriatric population and high disposable income
By type, the disposable segment is expected to register the highest CAGR during the forecast period owing to factors such as decreased infection risk and low maintenance cost
By application, the gynecology segment is expected to register the highest CAGR during the forecast period owing to the increasing preference of minimally invasive gynecologic surgeries resulting in shorter hospital stays
By end-use, the hospital segment accounted for the largest market share in 2019, as the hospital settings are equipped with technologically advanced devices for conducting minimally invasive surgeries.
Grand View Research has segmented the global bipolar forceps market based on type, application, end-use, and region:
Bipolar Forceps Type Outlook (Revenue, USD Million, 2016 - 2027)
Disposable
Reusable
Bipolar Forceps Application Outlook (Revenue, USD Million, 2016 - 2027)
Gynecology
General surgery
Neurosurgery
Plastic surgery
Others
Bipolar Forceps End-use Outlook (Revenue, USD Million, 2016 - 2027)
Hospitals
Specialty clinics
Ambulatory Surgical centers
Bipolar Forceps Regional Outlook (Revenue, USD Million, 2016 - 2027)
North America
U.S.
Canada
Europe
U.K.
Germany
France
Italy
Spain
Asia Pacific
Japan
China
India
South Korea
Australia
Latin America
Brazil
Mexico
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
List of Key Players of Bipolar Forceps Market
ConMed
Medtronic Plc
KLS Martin
B. Braun Melsungen AG
Stryker
Becton, Dickinson and Company
Johnson & Johnson
Integra LifeSciences
Stingray Surgical Products, LLC
Surgical Holdings
"The quality of research they have done for us has been excellent..."